对寄生虫原生动物疾病的药物重用
Vijayasurya1, Swadha Gupta1, Smit Shah1
1School of Life Sciences, Central University of Gujarat, Gandhinagar, Gujarat, India.
Progress in molecular biology and translational science
|June 28, 2024
概括
药物再利用提供了一种具有成本效益的策略,用于对抗原生虫寄生虫感染,解决耐药性和缺乏疫苗的问题. 这种方法识别了对被忽视的热带疾病具有新的治疗潜力的现有药物.
科学领域:
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
- 热带医学 热带医学
背景情况:
- 原生虫寄生虫对全球的健康和经济造成重大负担,特别是在热带地区.
- 像莱什曼病和疟疾这样的疾病每年导致超过一百万人死亡,这种疾病因耐药性和缺乏疫苗而恶化.
- 迫切需要新的,有效的抗寄生虫治疗方法.
研究的目的:
- 探索药物再利用作为开发新抗寄生虫疗法的可行策略.
- 概述有效的药物重用方法,并提出新的方法.
- 突出人类原生动物疾病重用药物的成功例子.
主要方法:
- 审查有关药物重用方法的现有文献.
- 分析已知药物的潜力,用于新的抗寄生虫应用.
- 确定协同作用的药物组合,以提高疗效.
- 对针对特定原生动物感染的重用药物的案例研究.
主要成果:
- 药物重新定位提供了一个更快,更经济的替代方案,而不是新的药物开发.
- 某些药物表现出超出其原始指示的有效性,有时具有协同效应.
- 重用药物在治疗各种原生动物感染方面表现出积极的结果.
结论:
- 药物重新定位是解决抗寄生虫药物发现挑战的强大工具.
- 创新策略可以克服障碍,最大限度地发挥重新定位药物的潜力.
- 成功的重新利用为改善原生动物疾病的治疗提供了希望.
更多相关视频
08:48In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
3.3K
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.3K
相关概念视频
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Overview of Protists
Protists are diverse eukaryotic microorganisms that lack the specialized tissues of plants and animals and the chitinous cell walls of fungi. Their early divergence within Eukarya resulted in structural, functional, and ecological diversity. They are classified into supergroups such as Archaeplastida, Excavata, Amoebozoa, Rhizaria, Alveolata, and Stramenopiles, determined through genetic analysis and structural similarities.Structural and Functional AdaptationsProtists have various adaptations...
Microbial Interactions: Parasitism
Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
